| abstract |
The invention provides compounds of formula I n n n n n n n n n n and pharmaceutically acceptable salts thereof. n The formula I thiazolyl compounds inhibit tyrosine kinase activity thereby making them useful as anticancer agents and for the treatment of Alzheimer's disease. |